A 53-year-old woman presented in 1987 with a short history of lethargy and weight loss of one stone. She had no symptoms referable to her gastrointestinal or genito -urinary tracts. In her past medical history she had undergone a radical left nephrectomy in 1969 for a renal carcinoma and in 1982 a partial right nephrectomy was carried out for a metachronous renal carcinoma. On both occasions histological examination confirmed a clear cell renal carcinoma with renal vein invasion, although the capsules were intact. On neither occasion had there been nodal involvement or detectable metastases. On admission she was anaemic but there were no other abnormal findings. Investigations revealed haemoglobin of 8-6 g/dl with microcytic hypochromic indices. ESR was 120 mm/hour. Biochemical screening of liver, kidney and bone was normal. Cytological and bacteriological examination of urine was negative. Chest, cardiograph and skeletal survey revealed no evidence of metastases. CT scan revealed a tumour in the body and tail of the pancreas. There was no evidence of hepatic or nodal metastases. At laparotomy a 5cm tumour was found in the body of the pancreas extending into the tail. There was no sign of extra -pancreatic tumour. A subtotal pancreatectomy, preserving the duodenum was performed. Post-operatively she made an uneventful recovery. Enzyme and insulin replacement was not required.
DISCUSSION
We report a patient with metachronous renal carcinomas treated surgically, who later developed a solitary pancreatic metastasis and who subsequently developed a secondary deposit in her thyroid gland. Renal carcinoma is an aggressive tumour; thirty percent have metastases at presentation and their prognosis is grave, 75% dying within one year. Stage III disease (renal vein invasion) carries a five year survival of 30% after nephrectomy.' A small number (1%) are found to have a solitary metastatic deposit at diagnosis, often in bone, brain or adrenal gland.2 Radical nephrectomy and excision of the metastases may produce up to 22 % two year survival.2 Despite successful nephrectomy, patients may develop metastases after variable disease free periods. In one large series, 11 % developed metastases more than 10 years after surgery.' In a few cases (1 -2%) recurrence is solitary and limited to one site. Aggressive surgery has yielded excellent results in these patients, with ten-year survival of up to 70%.2 3 Metastases are commonest in brain (30%), lung (30%) and bone (20%). In view of the potential for prolonged survival obtained by surgery, we recommend a similar approach to pancreatic metastases if it can be ascertained that the metastasis is truly solitary. There have been three previous reports of pancreatic resection under these circumstances and two of these patients were disease free after one year. 4' 5 We thank Dr J D Biggart for help in reviewing the histology of this case.
